Rein Pähkla

Discovery of a Novel Superpotent and Selective Melanocortin-4 Receptor Antagonist (HS024): Evaluation in Vitro and in Vivo**This work was supported by grants from the Swedish Medical Research Council (04X-05957), the Swedish Society for Medical Research, and the Estonian Science Foundation (Grant 3267); the Ants ja Maria Silvere ning Sigfried Panti Malestusstipendium Foundation (to A.K.); and the Swedish Institute (to I.M.).

Ants Kask, Felikss Mutulis, Ruta Muceniece et al. · Endocrinology · 1998 · 155 citations

Medicine, Medicinal Chemistry, Pharmacology +11

Selective Antagonist for the Melanocortin 4 Receptor (HS014) Increases Food Intake in Free-Feeding Rats

Ants Kask, Lembit Rägo, Felikss Mutulis et al. · Biochemical and Biophysical Research Communications · 1998 · 130 citations

Medicine, Neuroscience, Pharmacology +13

Chronic mild unpredictable stress after noradrenergic denervation: attenuation of behavioural and biochemical effects of DSP-4 treatment

Jaanus Harro, Riina Häidkind, Maarike Harro et al. · European Neuropsychopharmacology · 1999 · 98 citations

Life Sciences, Neuroscience, Pharmacology +17

Comparison of the antioxidant activity of melatonin and pinoline in vitro

Rein Pähkla, Mihkel Zilmer, Tiiu Kullisaar et al. · Journal of Pineal Research · 1998 · 75 citations

Life Sciences, Biochemistry, Pharmacology +14

MDR1 polymorphisms G2677T in exon 21 and C3435T in exon 26 fail to affect rhodamine 123 efflux in peripheral blood lymphocytes

Kersti Oselin, Thomas Gerloff, P.M. Mrozikiewicz et al. · Fundamental and Clinical Pharmacology · 2003 · 67 citations

Medicine, Genetics, Molecular Genetics +13